The Bone Health & Osteoporosis Foundation honors our more than 40-year history with Bone Talk, a podcast and blog that shares inspiring conversations. We examine issues around osteoporosis from diverse perspectives including patients, healthcare providers, caregivers, policy makers, researchers, advocates and innovators. Learn more about bone health, healthy active aging and strategies to protect your ability to live your best life.
EPISODE 84: FROM SCIENCE TO PATIENT CARE: UNDERSTANDING BIOSIMILARS IN OSTEOPOROSIS TREATMENT
On this episode of Bone Talk, Ami Patel, Vice President of Science and Education at the Bone Health and Osteoporosis Foundation, welcomes Cate Lockhart, PharmD, PhD, Chief Science Officer at the Academy of Managed Care Pharmacy and Executive Director of the Biologics and Biosimilars Collective Intelligence Consortium. Together, they discuss the science behind biosimilars, the FDA approval process, and how these medications may help make osteoporosis treatment more accessible and affordable.
EPISODE 83: FROM PREVENTION TO TREATMENT: ADVANCING MEN’S BONE
Osteoporosis isn't just a women's health issue. Men are also at risk for bone loss and broken bones, often without realizing it until a fracture occurs. In this episode of Bone Talk, BHOF Vice President of Science & Education Ami Patel talks with Annette Gantz, a board-certified family nurse practitioner specializing in osteoporosis and metabolic bone disease, about the importance of recognizing risk factors, getting appropriate screening and taking steps to protect bone health. From nutrition and exercise to treatment options and ongoing management, Annette shares practical information to help men reduce their risk of fractures, maintain mobility and preserve their independence as they age.
EPISODE 82: UNDERSTANDING BIOSIMILARS: A PATIENT’S QUESTIONS ANSWERED
One term patients may increasingly hear from their doctors, pharmacists, or health plans is "biosimilar." But what exactly is a biosimilar? Is it the same medication? Does it work the same way? Is it as safe? And what should a patient know if their doctor or insurance company recommends switching from a biologic medication they are already taking to a biosimilar? This episode approaches those questions from the patient perspective. Sally Fullman helps guide the conversation by asking the kinds of questions patients may have when they encounter biosimilars as part of their osteoporosis care. Answering those questions is Dr. Naga Yalla, an endocrinologist and Associate Professor of Medicine at Washington University School of Medicine.
Fundraise Your Own Way - Learn How!
The Bone Health & Osteoporosis Foundation (BHOF) is excited to introduce our new online fundraising platform, Fundraise Your Own Way! It’s an easy, flexible tool that helps you to create a personal page, share your story, and rally others to join you.